SCHEMBL30764768

SCHEMBL30764768

COC(=O)c1cc(OC)c(OCCCN2CCN(C)CC2)cc1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
HTR4 Q13639 4/20 0.49
CYP3A4 P08684 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.49
CYP2D6 P10635 2/20 0.49
KMT2A Q03164 2/20 0.49
HTR3A P46098 1/20 0.49
LMNA P02545 2/20 0.46
CYP1A2 P05177 1/20 0.46
SLC29A1 Q99808 2/20 0.46
CSF1R P07333 2/20 0.46
EHMT2 Q96KQ7 4/20 0.46
EHMT1 Q9H9B1 4/20 0.46
EGFR P00533 4/20 0.45
KDR P35968 4/20 0.45
ABCC4 O15439 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
CHRM3 P20309 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17375500 1.00 KDM4E (0.58) KDM4EHTR4CYP3A4ALDH1A1MEN1
SCHEMBL19260656 0.92 KDM4E (0.59) KDM4EHTR4CYP3A4ALDH1A1MEN1
SCHEMBL4379114 0.91 HTR4 (0.60) KDM4EHTR4CYP3A4ALDH1A1MEN1
SCHEMBL17375537 0.89 HTR4 (0.47) KDM4EHTR4CYP3A4ALDH1A1MEN1
SCHEMBL3711173 0.89 LMNA (0.56) KDM4EHTR4CYP3A4ALDH1A1MEN1
SCHEMBL3471214 0.89 LMNA (0.56) KDM4EHTR4CYP3A4ALDH1A1MEN1
SCHEMBL17375521 0.82 SIRT6 (0.51) KDM4ECYP3A4ALDH1A1CYP2D6LMNA
SCHEMBL2926517 0.81 HTR4 (0.56) HTR4CYP3A4ALDH1A1MEN1CYP2D6
SCHEMBL19260705 0.81 HTR4 (0.56) HTR4CYP3A4ALDH1A1MEN1CYP2D6
SCHEMBL6336768 0.81 HTR4 (0.62) HTR4CYP3A4ALDH1A1MEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111646940-B Preparation method of bosutinib intermediate 鲁南制药集团股份有限公司 2024-01-30 CN disclosed